Subscribe to Our Newsletter

© 2001-2020 by Bill White Limited

Registered in Scotland, No. SC642690

Group VAT GB342503923

WireNews ™ is a trademark of Bill White Limited

Privacy - Legal - DMCA

CrunchBase

  • White Facebook Icon
  • White Instagram Icon
  • YouTube
  • LinkedIn

Revolutionising Cancer Treatment With Genomics: Apply for Funding

Businesses can apply for a share of up to £5.4 million for projects that apply whole-genome sequencing to the analysis of cancer

Genomics - the study of all of a person’s genes - has the potential to revolutionise healthcare and could lead to many new cancer treatments.


Commercial applications of genomics to cancer are expected to make up a significant part of the predicted annual $22 billion global market for genomics by 2024.


The UK has already developed the largest, high-quality whole genome database in the world through the 100,000 Genomes Project.


A public-private collaboration is investing £200 million to complete the whole genome sequencing for the 500,000 participants in the UK Biobank.


Innovate UK, as part of UK Research and Innovation has up to £5.4 million from the government’s Industrial Strategy Challenge Fund (ISCF) to invest in projects that seek to apply whole-genome sequencing to the analysis of cancers.


This funding is part of the ISCF’s £210 million Data to Early Diagnosis and Precision Medicine Challenge. The challenge aims to fund researchers and industry to combine data and real-world evidence from UK health services and create new products and services that diagnose diseases earlier and more efficiently.


Find out more about the Data to Early Diagnosis and Precision Medicine Challenge


Aiming to encourage new cancer treatments

The competition aims to encourage new targeted cancer treatments based on the molecular signatures of cancer.


Projects must use whole-genome sequencing to analyse cancer and can adopt various approaches including development of reporting tools, identification of molecular signatures, identification of therapeutic targets, and new genetic signatures.


They can focus on one or more of:

improving diagnosis and prognosis of cancer and selection of therapies analysis of complex molecular signatures identification of tumours of unknown primary origin further analysis of existing whole-genome sequence data held by Genomics England the system of sample collection provided by the genomic medicine centres

The competition will support a range of work from short feasibility studies to partners working on larger research and development projects.


Find out more about applying for Innovate UK funding


Competition information

the competition opens today and the deadline for applications is at midday on 22 January 2020businesses of any size may apply, and all projects must include at least 1 SMEwe expect projects to range in size between £50,000 and £1 million briefing event will be held on 30 October 2019


Find out more about this competition and apply